SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-23-003495
Filing Date
2023-02-14
Accepted
2023-02-14 17:31:42
Documents
2
Period of Report
2023-01-04

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.html 4/A  
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.xml 4/A 6569
2 POWER OF ATTORNEY exhibit24.txt EX-24 1804
  Complete submission text file 0001062993-23-003495.txt   9807
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Issuer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address
Sullivan Edward Aloysius Jr. (Reporting) CIK: 0001929093 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41403 | Film No.: 23632073